Drug intelligence / Profile preview

Ziying Granules (Liaoning University of Traditional Chinese Medicine)

Development stage: Unknown
Lead developer: Liaoning University of Traditional Chinese Medicine
Administration: Oral

Overview

**Ziying Granules** is an investigational traditional Chinese medicine granular preparation developed by Liaoning University of Traditional Chinese Medicine for Henoch-Schönlein purpura. It was evaluated in the registered Phase 2 trial NCT01104428, which assessed a blood-cooling, toxin-removing, and stasis-dispersing treatment approach intended to reduce disease recurrence and renal damage. Publicly available trial information does not disclose the formulation's individual constituents, molecular targets, or a validated target-level mechanism of action.

Other names: \"ziying\" granules

Beyond the preview

Go deeper on Ziying Granules (Liaoning University of Traditional Chinese Medicine).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ziying Granules (Liaoning University of Traditional Chinese Medicine).

Explore the full profile